To validate the effects of the extract on cancer-related pathways, inhibition of the WNT/Beta-catenin pathway and TGF-beta signaling was tested by immunoblotting with main intracellular signaling elements anti-phospho-β-catenin and anti-SMAD2 antibodies, respectively. This evidence concerns the gene CTNNB1 and cancer.